{"id":"https://openalex.org/W1998799059","doi":"https://doi.org/10.1016/j.ymthe.2006.08.861","title":"775. Folate Receptor Targeted Virotherapy of Ovarian Cancer Using a Tropism Modified Measles Virus","display_name":"775. Folate Receptor Targeted Virotherapy of Ovarian Cancer Using a Tropism Modified Measles Virus","publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W1998799059","doi":"https://doi.org/10.1016/j.ymthe.2006.08.861","mag":"1998799059"},"language":"en","primary_location":{"id":"doi:10.1016/j.ymthe.2006.08.861","doi":"https://doi.org/10.1016/j.ymthe.2006.08.861","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ymthe.2006.08.861","pdf_url":"http://www.cell.com/article/S1525001606011233/pdf","source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-2","medline","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.cell.com/article/S1525001606011233/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021592961","display_name":"Kosei Hasegawa","orcid":"https://orcid.org/0000-0002-1751-6527","observed_orcids":["https://orcid.org/0000-0002-1751-6527"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kosei Hasegawa","raw_affiliation_strings":["Molecular Medicine Program, Mayo Clinic College of Medicine, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Medicine Program, Mayo Clinic College of Medicine, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071254876","display_name":"Takafumi Nakamura","orcid":"https://orcid.org/0000-0002-0196-0754","observed_orcids":["https://orcid.org/0000-0002-0196-0754"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Takafumi Nakamura","raw_affiliation_strings":["Molecular Medicine Program, Mayo Clinic College of Medicine, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Medicine Program, Mayo Clinic College of Medicine, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068461077","display_name":"Mary E. Harvey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary Harvey","raw_affiliation_strings":["Molecular Medicine Program, Mayo Clinic College of Medicine, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Medicine Program, Mayo Clinic College of Medicine, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050780337","display_name":"Yashiro Ikeda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yashiro Ikeda","raw_affiliation_strings":["Molecular Medicine Program, Mayo Clinic College of Medicine, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Medicine Program, Mayo Clinic College of Medicine, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069976109","display_name":"Ann L. Oberg","orcid":"https://orcid.org/0000-0003-2539-9807","observed_orcids":["https://orcid.org/0000-0003-2539-9807"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ann Oberg","raw_affiliation_strings":["Molecular Medicine Program, Mayo Clinic College of Medicine, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Medicine Program, Mayo Clinic College of Medicine, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087949502","display_name":"Mariangela Figini","orcid":"https://orcid.org/0000-0001-9001-8754","observed_orcids":["https://orcid.org/0000-0001-9001-8754"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mariangela Figini","raw_affiliation_strings":["Department of Experimental Oncology, Insituto Nazionale Tumori, Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Oncology, Insituto Nazionale Tumori, Milan, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037526893","display_name":"Silvana Canevari","orcid":"https://orcid.org/0000-0002-2963-3587","observed_orcids":["https://orcid.org/0000-0002-2963-3587"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Silvana Canevari","raw_affiliation_strings":["Department of Experimental Oncology, Insituto Nazionale Tumori, Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Oncology, Insituto Nazionale Tumori, Milan, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005798440","display_name":"Lynn C. Hartmann","orcid":"https://orcid.org/0000-0002-5931-7876","observed_orcids":["https://orcid.org/0000-0002-5931-7876"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lynn Hartmann","raw_affiliation_strings":["Molecular Medicine Program, Mayo Clinic College of Medicine, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Medicine Program, Mayo Clinic College of Medicine, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072521252","display_name":"Kah-Whye Peng","orcid":"https://orcid.org/0000-0002-9815-7721","observed_orcids":["https://orcid.org/0000-0002-9815-7721"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kah-Whye Peng","raw_affiliation_strings":["Molecular Medicine Program, Mayo Clinic College of Medicine, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Medicine Program, Mayo Clinic College of Medicine, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":{"value":4500,"currency":"USD","value_usd":4500},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.11933753,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"13","issue":null,"first_page":"S300","last_page":"S300"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11135","display_name":"Virology and Viral Diseases","score":0.005100000184029341,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12996","display_name":"Cancer Research and Treatments","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/measles-virus","display_name":"measles virus","score":0.8600000143051147},{"id":"https://openalex.org/keywords/folate-receptor","display_name":"folate receptor","score":0.8460000157356262},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/cd46","display_name":"CD46","score":0.6330000162124634},{"id":"https://openalex.org/keywords/attenuated-virus","display_name":"attenuated virus","score":0.6100000143051147},{"id":"https://openalex.org/keywords/immunosuppression-toxicity","display_name":"immunosuppression toxicity","score":0.6970000267028809}],"concepts":[{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.9355312585830688},{"id":"https://openalex.org/C2778199166","wikidata":"https://www.wikidata.org/wiki/Q573943","display_name":"Measles virus","level":4,"score":0.8835854530334473},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.7432467937469482},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6346189379692078},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.6065835952758789},{"id":"https://openalex.org/C49744831","wikidata":"https://www.wikidata.org/wiki/Q600121","display_name":"Virotherapy","level":4,"score":0.5898171663284302},{"id":"https://openalex.org/C35693153","wikidata":"https://www.wikidata.org/wiki/Q239762","display_name":"Tropism","level":3,"score":0.5853027701377869},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5807382464408875},{"id":"https://openalex.org/C106358424","wikidata":"https://www.wikidata.org/wiki/Q1662346","display_name":"Infectivity","level":3,"score":0.44791117310523987},{"id":"https://openalex.org/C33602714","wikidata":"https://www.wikidata.org/wiki/Q7809666","display_name":"Tissue tropism","level":4,"score":0.4354904890060425},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4354532063007355},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41651245951652527},{"id":"https://openalex.org/C2780355102","wikidata":"https://www.wikidata.org/wiki/Q1753162","display_name":"Mononegavirales","level":5,"score":0.41450974345207214},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3764153718948364},{"id":"https://openalex.org/C2776438120","wikidata":"https://www.wikidata.org/wiki/Q79793","display_name":"Measles","level":3,"score":0.23607909679412842},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.16257482767105103},{"id":"https://openalex.org/C2780813555","wikidata":"https://www.wikidata.org/wiki/Q911129","display_name":"Paramyxoviridae","level":4,"score":0.14918789267539978},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.11230197548866272},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.ymthe.2006.08.861","doi":"https://doi.org/10.1016/j.ymthe.2006.08.861","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ymthe.2006.08.861","pdf_url":"http://www.cell.com/article/S1525001606011233/pdf","source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-2","medline","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.ymthe.2006.08.861","doi":"https://doi.org/10.1016/j.ymthe.2006.08.861","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ymthe.2006.08.861","pdf_url":"http://www.cell.com/article/S1525001606011233/pdf","source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-2","medline","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.7900000214576721,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1998799059.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2001397790","https://openalex.org/W2174387488","https://openalex.org/W138586086","https://openalex.org/W2384093552","https://openalex.org/W1953735714","https://openalex.org/W4366091465","https://openalex.org/W4319761902","https://openalex.org/W2118430699","https://openalex.org/W4386844903","https://openalex.org/W1565993062"],"abstract_inverted_index":{"Attenuated":[0],"measles":[1,38],"viruses":[2],"are":[3],"being":[4],"evaluated":[5],"in":[6],"a":[7,20],"phase":[8],"I":[9],"dose":[10],"escalation":[11],"trial":[12],"for":[13,43],"ovarian":[14,74],"cancer":[15,75],"patients.":[16],"The":[17],"virus":[18,33],"encodes":[19],"soluble":[21],"marker":[22],"protein":[23],"to":[24,61,71],"facilitate":[25],"noninvasive":[26],"monitoring":[27],"of":[28,36,66],"viral":[29],"gene":[30],"expression.":[31],"This":[32],"uses":[34],"either":[35],"two":[37],"receptors,":[39],"CD46":[40],"and":[41,46,52,64],"SLAMV":[42],"binding,":[44],"entry,":[45],"subsequent":[47],"intercellular":[48],"fusion":[49],"between":[50],"infected":[51],"uninfected":[53],"neighboring":[54],"cells.":[55],"To":[56],"minimize":[57],"potential":[58],"toxicity":[59],"due":[60],"MV-associated":[62],"immunosuppression":[63],"infection":[65],"nontarget":[67],"tissues,":[68],"we":[69],"sought":[70],"develop":[72],"an":[73],"exclusive":[76],"fully":[77],"retargeted":[78],"MV.":[79]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2025-10-10T00:00:00"}